Cloud DX Signs New Palliative Contract with Ontario Healthcare Team

3 years ago

Healthcare team to use Connected Health™ kits to provide dignity in care for up to 85 patientsNews in SummaryCloud DX…

Biotricity to Launch Commercial Sales of Its Disruptive Cardiac Monitoring Device, Biotres in April 2022

3 years ago

Company reports pre-order sales from existing customers of its wireless wearable device for early detection of cardiac arrhythmiasREDWOOD CITY, CA…

NuGen M.D. and Unifire Inc. Announce Partnership to Market and Distribute its Needle-Free Injection Device to United States Government Agencies

3 years ago

Unifire to Focus on Immediate Opportunities within the Department of Defense (DoD), Biomedical Advanced Research and Development Authority (BARDA), Veteran…

Spago Nanomedical Presents its Platform Technology at ACS Spring Today

3 years ago

LUND, SE / ACCESSWIRE / March 22, 2022 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)Spago Nanomedical AB (publ) will present a poster summarizing…

Aytu BioPharma to Participate in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit

3 years ago

ENGLEWOOD, CO / ACCESSWIRE / March 22, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and…

Moderna Announces New Development Programs Ahead of 3rd Annual Vaccines Day

3 years ago

mRNA-1230 is a combination respiratory vaccine candidate against SARS-CoV-2 virus, influenza virus and respiratory syncytial virus (RSV)mRNA-1287 is a vaccine…

NeonMind Files New Provisional Patent Application Covering Novel Mechanism of Weight Loss

3 years ago

OAKVILLE, ON / ACCESSWIRE / March 22, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug…

Maimonides Medical Center Adopts Revolutionary Technology That Quickly Distinguishes Bacterial and Viral Infections

3 years ago

Maimonides Medical Center Adopts Revolutionary Technology That Quickly Distinguishes Bacterial and Viral Infections Maimonides is the first hospital in New…

InnoSIGN Completes Spin-Out from Philips with an $8M Series A Financing to Revolutionize Precision Medicine through its OncoSIGNal Pathway Activity Profiling Platform

3 years ago

InnoSIGN utilizes its proprietary database with over 100,000 pathway activity profiles for drug development and diagnostics to predict patient response…

Artelo Biosciences to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th

3 years ago

SOLANA BEACH, Calif., March 22, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical stage pharmaceutical company developing…